Tori Shaeffer

Development of a Novel GABA-A Agonist in Fragile X Syndrome

FRAXA funded analysis of a selective GABA-A drug for Fragile X, leading to a clinical trial at Cincinnati Children’s to test this potential treatment.

Read More »

Categories

FRAXA Funded Research

Current Research Grants (38)